[go: up one dir, main page]

GT201400071A - Combinación terapéutica para el tratamiento de cáncer - Google Patents

Combinación terapéutica para el tratamiento de cáncer

Info

Publication number
GT201400071A
GT201400071A GT201400071A GT201400071A GT201400071A GT 201400071 A GT201400071 A GT 201400071A GT 201400071 A GT201400071 A GT 201400071A GT 201400071 A GT201400071 A GT 201400071A GT 201400071 A GT201400071 A GT 201400071A
Authority
GT
Guatemala
Prior art keywords
cancer treatment
therapeutic combination
combinations
treatment
therapeutic
Prior art date
Application number
GT201400071A
Other languages
English (en)
Inventor
Dennis R Knocke
Joseph B Nester
Ioannis Papasotiriou
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of GT201400071A publication Critical patent/GT201400071A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/24—Apocynaceae (Dogbane family), e.g. plumeria or periwinkle
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/282—Platinum compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/665—Phosphorus compounds having oxygen as a ring hetero atom, e.g. fosfomycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/243—Platinum; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/886—Aloeaceae (Aloe family), e.g. aloe vera
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

LA PRESENTE INVENCIÓN SE RELACIONA CON COMBINACIONES TERAPÉUTICAS QUE COMPRENDEN UN AGENTE ANTINEOPLÁSICO BASADO EN PLATINO Y UN EXTRACTO DE UNA ESPECIE DEL GÉNERO NERIUM, ASÍ COMO MÉTODOS PARA USAR DICHAS COMBINACIONES EN EL TRATAMIENTO DE PACIENTES QUE SUFREN DE DETERMINADOS TIPOS DE CÁNCER
GT201400071A 2011-10-20 2014-04-15 Combinación terapéutica para el tratamiento de cáncer GT201400071A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201161549386P 2011-10-20 2011-10-20

Publications (1)

Publication Number Publication Date
GT201400071A true GT201400071A (es) 2015-09-17

Family

ID=48141445

Family Applications (1)

Application Number Title Priority Date Filing Date
GT201400071A GT201400071A (es) 2011-10-20 2014-04-15 Combinación terapéutica para el tratamiento de cáncer

Country Status (13)

Country Link
US (2) US20130209579A1 (es)
EP (2) EP2768498B1 (es)
JP (1) JP6255346B2 (es)
CN (2) CN104093405A (es)
AU (3) AU2012325819B2 (es)
BR (1) BR112014009421A2 (es)
CA (1) CA2852274C (es)
GT (1) GT201400071A (es)
IL (2) IL231987B (es)
IN (1) IN2014KN00796A (es)
MX (2) MX365635B (es)
RU (2) RU2017136415A (es)
WO (1) WO2013059753A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101717301B1 (ko) * 2008-10-14 2017-03-16 네리엄 바이오테크놀로지, 인크. 강심 배당체의 추출방법 및 조성물
JP6768702B2 (ja) * 2015-04-22 2020-10-14 シン−ナット プロダクツ エンタープライズ エルエルシー 共結晶組成物及びその医薬用途
JP7038653B2 (ja) * 2015-10-05 2022-03-18 ニューカナ パブリック リミテッド カンパニー 併用療法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MC1811A1 (fr) 1986-05-13 1988-03-18 Huseyin Ziya Ozel Extrait de plantes de l'espece nerium procede pour sa preparation et ses applications
EP1115411A1 (en) 1998-09-24 2001-07-18 Ozelle Pharmaceuticals, Inc. Extract of nerium species, pharmaceutical composition thereof and methods for preparation thereof
US7407675B2 (en) * 2002-12-27 2008-08-05 The Trustees Of Columbia University In The City Of New York Anti-neoplastic compositions comprising extracts of black cohosh
US20060205679A1 (en) * 2004-10-22 2006-09-14 Azaya Therapeutics, Inc. Topical and oral formulations of cardiac glycosides for treating skin diseases
US7402325B2 (en) 2005-07-28 2008-07-22 Phoenix Biotechnology, Inc. Supercritical carbon dioxide extract of pharmacologically active components from Nerium oleander
EP1803461A1 (en) 2005-12-27 2007-07-04 Heinz-Herbert Fiebig Therapeutic use of an extract from the leaves of Nerium oleander
ES2495743T3 (es) 2007-08-06 2014-09-17 Ohio University Fosfaplatinos y su uso en el tratamiento de cánceres resistentes a cisplatino y carboplatino
KR101717301B1 (ko) * 2008-10-14 2017-03-16 네리엄 바이오테크놀로지, 인크. 강심 배당체의 추출방법 및 조성물

Also Published As

Publication number Publication date
EP2768498A1 (en) 2014-08-27
EP3711754A1 (en) 2020-09-23
CA2852274C (en) 2019-08-06
RU2014120179A (ru) 2015-11-27
US20130209579A1 (en) 2013-08-15
AU2012325819B2 (en) 2017-08-03
MX2014004527A (es) 2014-09-15
AU2019203577A1 (en) 2019-06-13
JP2014530878A (ja) 2014-11-20
US20190343908A1 (en) 2019-11-14
MX2019006685A (es) 2019-08-21
CN104093405A (zh) 2014-10-08
CN110269940A (zh) 2019-09-24
IL275636A (en) 2020-08-31
EP2768498A4 (en) 2015-06-17
NZ623550A (en) 2016-06-24
RU2017136415A3 (es) 2021-02-08
IL231987B (en) 2020-07-30
IN2014KN00796A (es) 2015-10-02
WO2013059753A1 (en) 2013-04-25
MX365635B (es) 2019-06-10
AU2012325819A1 (en) 2014-04-24
BR112014009421A2 (pt) 2017-04-18
AU2017254875A1 (en) 2017-11-23
RU2017136415A (ru) 2019-02-08
IL231987A0 (en) 2014-05-28
EP2768498B1 (en) 2020-03-04
CA2852274A1 (en) 2013-04-25
JP6255346B2 (ja) 2017-12-27

Similar Documents

Publication Publication Date Title
SV2017005489A (es) Terapias de combinación para el tratamiento de cánceres
ECSP24031979A (es) Compuestos terapéuticamente activos y sus métodos de uso
UY36307A (es) Terapias combinadas para el tratamiento del cáncer
CR20150376A (es) Compuestos sustituidos de pirrolopirimidina, compuestos de los mismos y metodos de tratamiento con los mismos
MX2015010724A (es) Terapia de combinacion que involucra anticuerpos contra claudina 18.2 para tratamiento de cancer.
CL2015000699A1 (es) Métodos para tratamiento de cáncer.
MX373187B (es) Terapia de combinación para tratar cáncer.
CL2015002807A1 (es) Terapia de combinación
MX2021013837A (es) Enfoque de inmunoterapias de combinacion para el tratamiento del cancer.
MX379297B (es) Compuestos alqueno tetrasustituidos y su uso.
MX2015011753A (es) Metodos para tratar cancer de vegija.
MX2019003134A (es) Terapia de combinacion.
NI201400095A (es) Metodos para el tratamiento del cáncer de pulmon de celulas no pequeñas utilizando terapia combinada de inhibidor tor cinasa.
NI201400112A (es) Tratamiento del cáncer con inhibidores tor cinasa
NI201400111A (es) Tratamiento del cáncer con inhibidores tor cinasa
MX374749B (es) Terapia de combinacion que comprende un inhibidor de tor cinasa y un analogo de citidina para tratar cancer.
ECSP15011764A (es) Antiandrógenos para el tratamiento del cáncer de próstata resistente a la castración no metastásico
NI201500063A (es) Tratamiento de cáncer con pomalidomida en un individuo con daño renal
MX2020001727A (es) Terapia de combinacion.
CR20140400A (es) Terapia combinada para el tratamiento del cancer de ovario
MX2016015161A (es) Metodos de tratamiento de cancer de mama luminal a positivo para pr con inhibidor de pi3k, pictilisib.
DOP2018000011A (es) Sales y profármacos de 1-metil-d-triptófano
MX2018013873A (es) Irinotecan nanoliposomico para usarse en el tratamiento del cancer de pulmon de celulas pequeñas.
MX382776B (es) Uso de levocetirizina y montelukast en el tratamiento de lesion traumatica.
GT201400071A (es) Combinación terapéutica para el tratamiento de cáncer